Hochhaus A, Baccarani M, Silver RT, Schiffer C, Apperley JF, Cervantes F, et al. Chronic myelogenous leukemia European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia. Leukemia. 2020;34:966–84. https://doi.org/10.1038/s41375-020-0776-2.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Soverini S, Branford S, Nicolini FE, Talpaz M, Deininger MW, Martinelli G, et al. Implications of BCR-ABL1 kinase domain-mediated resistance in chronic myeloid leukemia. Leuk Res. 2014;38:10. https://doi.org/10.1016/j.leukres.2013.09.011.

Article  CAS  PubMed  Google Scholar 

Kim T, Tyndel MS, Joon Kim H, Ahn JS, Hyun Choi S, Jeong Park H, et al. Spectrum of somatic mutation dynamics in chronic myeloid leukemia following tyrosine kinase inhibitor therapy Running Title: Dynamic patterns of somatic mutations in CML. Blood. 2016;129:38–47. https://doi.org/10.1182/blood-2016-04-708560.

Article  CAS  PubMed  Google Scholar 

Jabbour E, Kantarjian H, Jones D, Talpaz M, Bekele N, O’Brien S, et al. Frequency and clinical significance of BCR::ABL mutations in patients with chronic myeloid leukemia treated with imatinib mesylate. Leukemia. 2006;20:1767–73. https://doi.org/10.1038/sj.leu.2404318.

Article  CAS  PubMed  Google Scholar 

Cortes JE, Kim DW, Pinilla-Ibarz J, Le Coutre P, Paquette R, Chuah C, et al. A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias. N Engl J Med. 2013;369:1783–96. https://doi.org/10.1056/NEJMoa1306494.

Article  CAS  PubMed  Google Scholar 

Giri S, Pathak R, Martin MG, Bhatt VR. Characteristics and survival of BCR/ABL negative chronic myeloid leukemia: a retrospective analysis of the surveillance, epidemiology and end results database. Ther Adv Hematol. 2015;6:308–12. https://doi.org/10.1177/2040620715607416.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Corbin AS, Agarwal A, Loriaux M, Cortes J, Deininger MW, Druker BJ. Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR::ABL activity. J Clin Invest. 2011;121:396–409. https://doi.org/10.1172/JCI35721.

Article  CAS  PubMed  Google Scholar 

Clarke CJ, Holyoake TL. Preclinical approaches in chronic myeloid leukemia: from cells to systems. Exp Hematol. 2017;47:13–23. https://doi.org/10.1016/j.exphem.2016.11.005.

Article  PubMed  PubMed Central  Google Scholar 

Alves R, Gonçalves AC, Rutella S, Almeida AM, De Las RJ, Trougakos IP, et al. Resistance to tyrosine kinase inhibitors in chronic myeloid leukemia—from molecular mechanisms to clinical relevance. Cancers. 2021;13:4820. https://doi.org/10.3390/cancers13194820.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alison MR, Lim SM, Nicholson LJ. Cancer stem cells: problems for therapy? J Pathol. 2011;223:148–62. https://doi.org/10.1002/path.2793.

Article  CAS  Google Scholar 

Baghdadi TA, Abonour R, Boswell HS. Novel combination treatments targeting chronic myeloid leukemia stem cells. Clin Lymphoma Myeloma Leuk. 2012;12:94–105. https://doi.org/10.1016/j.clml.2011.10.003.

Article  CAS  PubMed  Google Scholar 

Irvine DA, Zhang B, Kinstrie R, Tarafdar A, Morrison H, Campbell VL, et al. Deregulated hedgehog pathway signaling is inhibited by the smoothened antagonist LDE225 (Sonidegib) in chronic phase chronic myeloid leukaemia. Sci Rep. 2016;6:25476. https://doi.org/10.1038/srep25476.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Donato NJ, Wu JY, Stapley J, Gallick G, Lin H, Arlinghaus R, et al. BCR::ABL independence and LYN kinase overexpression in chronic myelogenous leukemia cells selected for resistance to STI571. Blood. 2003;101:690–8. https://doi.org/10.1182/blood.V101.2.690.

Article  CAS  PubMed  Google Scholar 

Elias D, Ditzel HJ. The potential of Src inhibitors. Aging (Albany NY). 2015;7:734. https://doi.org/10.18632/aging.100821.

Article  PubMed  Google Scholar 

Laperrousaz B, Jeanpierre S, Sagorny K, Voeltzel T, Ramas S, Kaniewski B, et al. Primitive CML cell expansion relies on abnormal levels of BMPs provided by the niche and on BMPRIb overexpression. Blood. 2013;122:3767–77. https://doi.org/10.1182/blood-2013-05-501460.

Article  CAS  PubMed  Google Scholar 

Grockowiak E, Laperrousaz B, Jeanpierre S, Voeltzel T, Guyot B, Gobert S, et al. Immature CML cells implement a BMP autocrine loop to escape TKI treatment. Blood. 2017;130:2860–71. https://doi.org/10.1182/blood-2017-08-801019.

Article  CAS  PubMed  Google Scholar 

Toofan P, Busch C, Morrison H, O’Brien S, Jørgensen H, Copland M, et al. Chronic myeloid leukaemia cells require the bone morphogenic protein pathway for cell cycle progression and self-renewal. Cell Death Dis. 2018;9:927. https://doi.org/10.1038/s41419-018-0905-2.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gerber JM, Gucwa JL, Esopi D, Gurel M, Haffner MC, Vala M, et al. Genome-wide comparison of the transcriptomes of highly enriched normal and chronic myeloid leukemia stem and progenitor cell populations. Oncotarget. 2013;4:715. https://doi.org/10.18632/oncotarget.990.

Article  PubMed  PubMed Central  Google Scholar 

Schenone S, Brullo C, Musumeci F, Botta M. Novel dual Src/Abl inhibitors for hematologic and solid malignancies. Expert Opin Investig Drugs. 2010;19:931. https://doi.org/10.1517/13543784.2010.499898.

Article  CAS  PubMed  Google Scholar 

Green TP, Fennell M, Whittaker R, Curwen J, Jacobs V, Allen J, et al. Preclinical anticancer activity of the potent, oral Src inhibitor AZD0530. Mol Oncol. 2009;3:248–61. https://doi.org/10.1016/j.molonc.2009.01.002.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carvalho D, Taylor KR, Olaciregui NG, Molinari V, Clarke M, Mackay A, et al. ALK2 inhibitors display beneficial effects in preclinical models of ACVR1 mutant diffuse intrinsic pontine glioma. Commun Biol. 2019;2:156. https://doi.org/10.1038/s42003-019-0420-8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Williams E, Bagarova J, Kerr G, Xia DD, Place ES, Dey D, et al. Saracatinib is an efficacious clinical candidate for fibrodysplasia ossificans progressiva. JCI Insight. 2021;6(8):e95042. https://doi.org/10.1172/jci.insight.95042.

Article  PubMed  PubMed Central  Google Scholar 

Chou TC. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev. 2006;58:621–81. https://doi.org/10.1124/pr.58.3.10.

Article  CAS  PubMed  Google Scholar 

Chou TC. Drug combination studies and their synergy quantification using the chou-talalay method. Cancer Res. 2010;70:440–6. https://doi.org/10.1158/0008-5472.CAN-09-1947.

Article  CAS  PubMed  Google Scholar 

Mulholland TE, McAllister M, Patek S, Flint D, Underwood M, Sim A, et al. Drug screening of biopsy-derived spheroids using a self-generated microfluidic concentration gradient. Sci Rep. 2018;8:14672. https://doi.org/10.1038/s41598-018-33055-0.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bolte S, Cordelières FP. A guided tour into subcellular colocalization analysis in light microscopy. J Microsc. 2006;224:213–32. https://doi.org/10.1111/j.1365-2818.2006.01706.x.

Article  CAS  PubMed  Google Scholar 

Graham SM, Jørgensen HG, Allan E, Pearson C, Alcorn MJ, Richmond L, et al. Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro. Blood. 2002;99:319–25. https://doi.org/10.1182/blood.v99.1.319.

Article  CAS  PubMed  Google Scholar 

Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102:15545–50. https://doi.org/10.1073/pnas.0506580102.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003;34:267–73. https://doi.org/10.1038/ng1180.

Article  CAS  PubMed  Google Scholar 

Liberzon A, Birger C, Thorvaldsdóttir H, Ghandi M, Mesirov JP, Tamayo P. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 2015;1:417–25. https://doi.org/10.1016/j.cels.2015.12.004.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Santos JC, Carrasco-Garcia E, Garcia-Puga M, Aldaz P, Montes M, Fernandez-Reyes M, et al. SOX9 elevation acts with canonical WNT signaling to drive gastric cancer progression. Cancer Res. 2016;76:6735–46. https://doi.org/10.1158/0008-5472.CAN-16-1120.

Article  CAS  PubMed